We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Heart Association Issues Statement on Understanding Radiation Risks Before Cardiac Imaging

By HospiMedica International staff writers
Posted on 16 Oct 2014
People should understand why a heart-imaging test is needed before undergoing the procedure, including the benefits and risks involved, such as the potential long-term risk from radiation exposure, advises a new scientific statement. More...


The statement was published online, before print, on September 29, 2014, in the American Heart Association’s (AHA; Dallas, TX, USA) journal Circulation. “When medical imaging is being considered, patients should feel very comfortable asking how the test will help them and the possible risks, including radiation-related risks,” said Reza Fazel, MD, MSc, chair of the writing committee for the statement and an AHA volunteer currently serving on the Joint Cardiac Imaging Committee of the AHA’s Council on Clinical Cardiology and Council on Cardiovascular Radiology.

As technology has evolved, imaging modalities have become an increasingly important application in diagnosing and treating patients with heart disease. However, the rising use has resulted in higher radiation exposure during the last 20 years. Heart imaging now accounts for nearly 40% of the radiation exposure patients receive from medical tests, according to the statement.

“In general, the radiation-related risk of any imaging test to an individual patient is very small and, when the test is clinically appropriate, the benefits of the test typically far outweigh any potential risks,” said Dr. Fazel, a cardiologist at Beth Israel Deaconess Medical Center (Boston, MA, USA).

Some questions that may help a patient understand the risks and benefits are: (1) how will this test help diagnose or treat my heart problem? (2) Will the results of this test change the recommended treatment? (3) Are there other techniques to get the information without using radiation? (4) How much radiation exposure may occur? (5) How could that affect my chance of developing cancer later in life? (6) Lastly, how does that risk compare to the risk from other common activities?

The most typically used heart and blood vessel imaging procedures using radiation are nuclear stress tests, cardiac computed tomography (CT) scans and fluoroscopy (a real-time X-ray technology used to guide catheter and device placement during heart catheterization and tests for heart rhythm abnormalities). Echocardiography and cardiac magnetic resonance imaging do not expose patients to ionizing radiation.

The new statement also provides guidance for the training of professionals who order or administer cardiac imaging tests. Clinicians planning imaging tests should understand when each type of test is appropriate, the typical average radiation dose and the potential risks. In deciding the best imaging method to use, the clinician should also consider the test’s diagnostic accuracy, potential risks, cost, availability, and the patient’s convenience.

“Radiation-related risk is one of the factors that should be considered in the decision to use cardiovascular imaging with ionizing radiation, particularly in younger patients in whom the potential risk of radiation exposure is thought to be higher,” Dr. Fazel said.

Clinicians who perform cardiac imaging should understand current methods required to select the optimal dose of radiation—using enough to produce high-quality imaged, not significantly more than that. They should also know how to minimize radiation exposure to staff, according to the statement.

Related Links:

American Heart Association
Beth Israel Deaconess Medical Center



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.